Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company offers Platinum NGPS instrument that provides single molecule amino acid level resolution with a streamlined workflow, including automated data analysis that accessible to researchers in all laboratory types; Platinum Pro NGPS instrument, a single molecule amino acid resolution, which provides an enhanced user interface, cloud or on instrument data analysis and an available pro mode; Library preparation kits to prepare protein sample for sequencing; Barcoding Kits to optimize the workflow and performance of technology; and Sequencing Kits contains the reagents and consumables used to perform NGPS on the Platinum or Platinum Pro instrument. It also provides Platinum Analysis Software, a cloud-based solution that automates data analysis workflows and provides a user-friendly interface and visualization of the sequencing results. Its products are used in antibody characterization, biomarker identification, protein identification, protein variants, protein barcoding, and post translational modification analysis applications. Quantum-Si incorporated was founded in 2013 is headquartered in Branford, Connecticut.
Metrics to compare | QSI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipQSIPeersSector | |
---|---|---|---|---|
P/E Ratio | −2.4x | −1.4x | −0.5x | |
PEG Ratio | 0.76 | −0.16 | 0.00 | |
Price/Book | 1.2x | 0.6x | 2.6x | |
Price / LTM Sales | 75.4x | 1.7x | 3.3x | |
Upside (Analyst Target) | 136.2% | 100.0% | 43.5% | |
Fair Value Upside | Unlock | 31.9% | 6.8% | Unlock |